✦ LIBER ✦

Weekly docetaxel as II line therapy in non-small cell lung cancer: an interim analysis of a phase II study

✍ Scribed by Valerio, Maria Rosaria; Russo, Antonio; Latteri, Mario Adelfio; Modica, Giuseppe; Gulotta, Gaspare; Armata, Maria Gabriella; Bajardi, Eugenia; Cicero, Giuseppe; Pantuso, Giovanni; Grassi, Nello; Agosta, Giacoma; Gebbia, Nicola

Book ID: 118570708
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 74 KB
Volume: 34
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(01)00402-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II trial of weekly docetaxel (D) i

Phase II trial of weekly docetaxel (D) in second-line non-small cell lung cancer (NSCLC)

✍ Lilenbaum, R; Schwartz, M; Siegel, L; Belette, F; Blaustein, A; Wittlin, F; Cisn 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 114 KB

Phase II study of weekly plitidepsin as

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

✍ Eisen, Tim; Thatcher, Nick; Leyvraz, Serge; Miller, Wilson H.; Couture, Felix; L 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 143 KB

Phase II study of weekly paclitaxel as s

Phase II study of weekly paclitaxel as second-line therapy in patients with advanced non-small cell lung cancer

✍ Ceresoli, Giovanni Luca; Gregorc, Vanesa; Cordio, Stefano; Bencardino, Katia Bru 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Phase II trial of weekly docetaxel and g

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

✍ Sujith Kalmadi; Giles McNeill; Mellar Davis; David Peereboom; David Adelstein; T 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 68 KB

P-537 A phase II study of carboplatin an

P-537 A phase II study of carboplatin and weekly docetaxel in advanced non-small cell lung cancer

✍ Moore, T.; Patel, T.; Segal, M.; Thompson, J.; Zangmeister, J.; Larrimer, N.; Me 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 297 KB

A multi-center phase II study of weekly

A multi-center phase II study of weekly topotecan as second-line therapy for small cell lung cancer

✍ SHAH, C; READY, N; PERRY, M; KIRSHNER, J; GAJRA, A; NEUMAN, N; GARZIANO, S 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 260 KB